ClinicalTrials.govpublic full text
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
solid tumours harboring nrg1 fusion, nsclc harboring nrg1 fusion, pancreatic cancer harboring nrg1 fusion, nrg1 fusion, bispecific antibody igg1, her2, her3, mcla-128, antibodies, bispecific, immunologic factors, solid tumor, pancreatic cancer, pdac, non-small cell lung cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 887804
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.